CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

NCT04988386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation

NCT04792190 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

NCT03756285 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction

NCT05350969 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

NCT00907998 ·Status: COMPLETED ·Phase: PHASE1

Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy

NCT01151137 ·Status: TERMINATED ·Phase: PHASE3

Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease

NCT05294887 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

NCT00595673 ·Status: COMPLETED ·Phase: PHASE3

Explorative Study of AZD1305 in Atrial Fibrillation Patients

NCT00643448 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058

NCT03708146 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

NCT06979362 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%

NCT04986202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

NCT03552575 ·Status: COMPLETED ·Phase: PHASE3

Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure

NCT00739687 ·Status: TERMINATED ·Phase: PHASE2

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

NCT06979375 ·Status: RECRUITING ·Phase: PHASE2

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

NCT00655538 ·Status: COMPLETED ·Phase: PHASE2

Spironolactone Therapy in Chronic Stable Right HF Trial

NCT03344159 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT06005428 ·Status: TERMINATED ·Phase: PHASE2

Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy

NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2

Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453

NCT02840565 ·Status: COMPLETED ·Phase: PHASE1

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

NCT03217331 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

NCT03860935 ·Status: COMPLETED ·Phase: PHASE3

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

NCT04363697 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

NCT00595244 ·Status: COMPLETED ·Phase: PHASE3